News about COVID-19

KUALA LUMPUR (May 1): Kuala Lumpur and Selangor residents who want to take the AstraZeneca Covid-19 vaccine will be able to book their slots from noon tomorrow on a "first click, first served" basis.

KUALA LUMPUR (April 30): Malaysia’s daily Covid-19 cases stayed above the 3,000 mark for the third straight day, as 3,788 new infections were reported in the last 24 hours, according to health director-general Tan Sri Dr Noor Hisham Abdullah.

KUALA LUMPUR (April 29): Kuala Lumpur has an average of 1,554 cases of Covid-19 per 100,000 population from Jan 1 to April 29, exceeding the national average of 853 cases and leading all the states.

KUALA LUMPUR (April 30): Individuals aged between 20 and 29 showed the highest Covid-19 cases incidence rate in the country per 100,000 population so far this year, according to the Ministry of Health (MoH) in a tweet.

KUALA LUMPUR (April 29): Malaysia saw Covid-19 cases rise to 3,332 today, from 3,142 reported yesterday, marking the second straight day new infections have breached the 3,000-case threshold.

KUALA LUMPUR (April 28): Malaysia's new Covid-19 cases jumped to 3,142 today — the highest in four months, bringing the number of active cases that have high transmission risks to 26,719 in the country.

KUALA LUMPUR (April 28): The government will not include the AstraZeneca vaccine under the National Covid-19 immunisation programme, said coordinating minister Khairy Jamaluddin.

KUALA LUMPUR (April 27): New Covid-19 infections in the country stood at 2,733 today, marking the 17th day where the daily figure was above 2,000 cases.

KUALA LUMPUR (April 27): The manager of YTL Corp Bhd-linked Starhill Global REIT, which owns the Lot 10 Property and The Starhill retail and hospitality entity along Jalan Bukit Bintang here, said the property trust remains cautious as the impact of the Covid-19 pandemic on its tenants’ businesses remains uncertain.

KUALA LUMPUR (April 27): Property developer Yong Tai Bhd said its healthcare subsidiary has obtained approval from the Ministry of Health's Medical Review & Ethics Committee (MREC) for its Phase III clinical trial study of inactivated Covid-19 trial vaccines in Malaysia.